Top investors predict what's ahead for healthcare and biotech in 2022
Hello, Welcome to Insider Healthcare. I'm healthcare editor Leah Rosenbaum, and this week in healthcare news:Our team talked to 15 of the top VCs in
Tag : Dispensed
Here's how companies can fundamentally change how we pay for healthcare
BI GraphicsDr. Farzad Mostashari, CEO, AledadeTom Sandner for Insider Employers and insurers can reward preventive healthcare instead of expensive
We looked at what conditions receive the most research funding compared with the leading causes of death in the US. Here's what we learned from 2021.
A digitally generated representation of the SARS-CoV-2 virus.Andriy Onufriyenko/Getty Images Heart disease, cancer, COVID-19, unintentional injuries,
See the leaders shaping healthcare and biotech today
Hello,Welcome to Insider Healthcare. I'm healthcare editor Leah Rosenbaum, and today in healthcare news:We've made lists of the top healthcare power
See the top power players influencing healthcare today, from Google execs to biotech VCs
Dr. Isaac Kinde, the head of research and innovation and a cofounder of Thrive; Dr. Asima Ahmad, Carrot Fertility's cofounder and chief medical
Meet the MIT professor who thinks he's found biotech's 'holy grail'
Hello,Welcome to Insider Healthcare. I'm healthcare editor Leah Rosenbaum, and today in healthcare news:A finance whiz thinks he may have solved
Biotech's top investors, ranked [Silicon Alley Insider]
Hello,Welcome to Insider Healthcare. I'm healthcare editor Leah Rosenbaum, and today in healthcare news:We ranked the top biotech investors of 2021
Biotech's top investors, ranked
Hello,Welcome to Insider Healthcare. I'm healthcare editor Leah Rosenbaum, and today in healthcare news:We ranked the top biotech investors of 2021
A top healthcare investor reveals the new way she's backing startups
Hello,Welcome to Insider Healthcare. I'm healthcare editor Leah Rosenbaum, and today in healthcare news:One of healthcare's top investors, Annie
A top healthcare investor reveals the new way she's backing startups [Silicon Alley Insider]
Hello,Welcome to Insider Healthcare. I'm healthcare editor Leah Rosenbaum, and today in healthcare news:One of healthcare's top investors, Annie
Most Omicron cases have been mild so far, but experts say we still need more data
Hello,Welcome to Insider Healthcare. I'm healthcare editor Leah Rosenbaum, and today in healthcare news:Most Omicron cases so far have been mild, but
Most Omicron cases have been mild so far, but experts say we still need more data [Silicon Alley Insider]
Hello,Welcome to Insider Healthcare. I'm healthcare editor Leah Rosenbaum, and today in healthcare news:Most Omicron cases so far have been mild, but
An FDA expert panel narrowly supports the first COVID-19 pill but suggests restrictions on its use driven by safety concerns [Silicon Alley Insider]
Molnupiravir is an experimental oral antiviral developed by Merck and Ridgeback Biotherapeutics that could treat COVID-19Merck The first COVID-19
An FDA expert panel narrowly supports the first COVID-19 pill but suggests restrictions on its use driven by safety concerns
Molnupiravir is an experimental oral antiviral developed by Merck and Ridgeback Biotherapeutics that could treat COVID-19Merck The first COVID-19
An FDA expert panel narrowly supports the first COVID-19 pill but suggests restrictions on its use driven by safety concerns
Molnupiravir is an experimental oral antiviral developed by Merck and Ridgeback Biotherapeutics that could treat COVID-19Merck The first COVID-19